Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study

OBJECTIVE: To obtain real-world data on outcomes of belimumab treatment and respective prognostic factors in patients with systemic lupus erythematosus (SLE). METHODS: Observational study of 188 active SLE patients (median disease duration 6.2 years, two previous immunosuppressive/biological agents)...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikoloudaki, Myrto, Nikolopoulos, Dionysis, Koutsoviti, Sofia, Flouri, Irini, Kapsala, Noemin, Repa, Argyro, Katsimbri, Pelagia, Theotikos, Evangelos, Pitsigavdaki, Sofia, Pateromichelaki, Katerina, Bertsias, Antonios, Elezoglou, Antonia, Sidiropoulos, Prodromos, Fanouriakis, Antonis, Boumpas, Dimitrios, Bertsias, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845912/
https://www.ncbi.nlm.nih.gov/pubmed/36685524
http://dx.doi.org/10.3389/fimmu.2022.1074044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845912/
https://www.ncbi.nlm.nih.gov/pubmed/36685524
http://dx.doi.org/10.3389/fimmu.2022.1074044

Ejemplares similares